1. DOSE- AND TIME- DEPENDENT PHARMACOKINETICS

2. CAUSES OF DOSE- OR TIME-DEPENDENT KINETICS PROCESS EXAMPLEPARAMETER Saturable gut wall transport riboflavin F Saturable gut wall metabolism salicylamideF Poor solubilitygriseofulvinF Saturable plasma protein bindingdisopyramidef up Active tubular secretionpenicillin GCL R Active tubular reabsorptionascorbic acidCL R Alterations in urine pHsalicylic acidCL R Alterations in urine flowtheophyllineCL R NephrotoxicitygentamicinCL R

3. CAUSES OF DOSE- OR TIME-DEPENDENT KINETICS PROCESS EXAMPLEPARAMETER Capacity-limited metabolismphenytoinCL H AutoinductioncarbamazepineCL H Co-substrate depletionacetaminophenCL H Product (metabolite) inhibitionphenylbutazone CL H

4. I. ABSORPTION Effect of dose on riboflavin urinary recovery when given on an empty stomach. Date from: Levy G, Jusko WJ. Factors affecting the absorption of riboflavin in man. J Pharm Sci 55:285-289, 1966.

5. Effect of dose on ascorbic acid absorption. Data from Blanchard J et al. Am J Clin Nutr 66:1165-1171, 1997

6. Steady-state Vitamin C plasma concentration as a function of dose in 13 female subjects receiving doses from 30 to 2,500 mg. From: Levine M, et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:9842-9846, 2001.

7. From: Levine M, et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:9842-9846, 2001.

8. Reproduced from: Rowland M, Tozet TN. Clinical Pharmacokinetics – Concepts and Applications, 3 rd edition, 1995, p. 397.

9. Reproduced from: Rowland M, Tozer TN. Ibid, p. 396.

10. II. ELIMINATION A. CAPACITY-LIMITED ELIMINATION 1. MATHEMATICAL ANALYSIS These processes can be described via the Michaelis- Menten relationship:

13. k -1 is a dissociation process, whereas k+2 requires the breaking of bonds; thus, k -1 >>k +2

14. Remember that [E f ] = [E T ] – [ES]

16. The rate of formation of the product is given as: By implication, the maximum rate is given as

18. For most drugs, K m >>C. Hence

19. Since Vmax and Km are constant for a given drug in a given individual, this ratio will be constant. Elimination will proceed in a first-order fashion.

20. Drugs for which K m << C: ethanolsalicylatephenytoin Numerous drugs after first-pass

21. 2. Clinical Consequences a. Relationship btwn dose and C p Reproduced from: Tozer TN, Winter ME. Phenytoin, In: Evans WE, Schentag JJ, Jusko WJ, Applied Pharmacokinetics – Principles for Therapeutic Drug Monitoring. 3 rd edition, 1992, p. 25-12

22. b. Relationship btwn dose and time to steady-state From: Ibid.

23. c. Relationship btwn dose and AUC o Plasma AUC of lorcainide in a subject as a function of dose. Data from: Janchen E et al. Clin Pharmacol Ther 26:187, 1979.

24. c. Relationship btwn dose and AUC o Plasma AUC/Dose of lorcainide in a subject as a function of dose. Data from: Janchen E et al. Clin Pharmacol Ther 26:187, 1979.

25. d. Relationship btwn dose and bioavailability Bioavailability of nicardipine after oral administration. Data from: Wagner JG et al. Biopharm Drug Dispos 8:133- 148, 1987.

26. e. Relationship btwn Cp and time

27. 3. Determination of Michaelis-Menten Parameters a. Lineweaver-Burke Expression 1/v 1/C 1/K m 1/V max Slope = K m /V max

28. b. In Vivo Determination K0K0K0K0 K 0 /C ss V max KmKmKmKm

29. JB is an 18 yo male receiving phenytoin for prophylaxis of post-traumatic head injury seizures. The following steady state concentrations were obtained at the indicated doses: Dose (mg/d) Css (mg/L) 1003.7 1003.7 30047 30047 From this data, determine this patients K m and V max for phenytoin.

30. JB is an 18 yo male receiving phenytoin for prophylaxis of post-traumatic head injury seizures. The following steady state concentrations were obtained at the indicated doses: Dose (mg/d) Css (mg/L) Dose Rate/Css (L/d) 1003.727 1003.727 300476.4 300476.4 K 0 (mg/d) K 0 /C ss (L/d) V max = 362 mg/d K m = 9.7 mg/L

31. What C ss would be expected if a dose of 200 mg/d were given to this patient?

32. 4. Application to Alcohol Avg V max = 10 g/hr K m = 100 mg/L K m = 100 mg/L Detectable pharmacologic effect: 250 mg/L Lethal concentrations >7000 mg/L

33. Note: EtOH metabolism becomes zero-order. One jigger (45 mL) of 80 proof EtOH contains ~14 g of ethanol – which exceeds the Vmax! Data from: Rowland M, Tozer TN. Ibid, p. 406.

34. Reproduced from: Ibid, p. 408.

36. B. Autoinduction

38. C. Saturable Renal Tubular Reabsorption Steady-state plasma ascorbic acid concentration in healthy adults receiving various regimens twice daily for 3 to 4 weeks. Control subjects had no supplement. Estimated daily dietary intake of ascorbic acid was 50- 75 mg. From: Nutr Rep Intern 30:597-601, 1984.

39. Reproduced from: Rowland M, Tozer TN. Ibid, p. 404.

40. III. SATURABLE PROTEIN BINDING Dose vs AUC for naproxen after single (AUCs) and multiple (AUCm) doses. From: Clin Pharmacol Ther 15:261-266, 1974.

41. In vitro binding of naproxen as a function of Cp.

43. Relationship between oral clearance and fraction unbound of oxaprozin. From: J Clin Pharmacol 36:985-997, 1996.